- Home
- BOLT vs EQS Comparison
BOLT vs EQS Comparison
Compare BOLT & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- EQS
- Stock Information
- Founded
- BOLT 2015
- EQS 1991
- Country
- BOLT United States
- EQS United States
- Employees
- BOLT N/A
- EQS N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- BOLT Health Care
- EQS Finance
- Exchange
- BOLT Nasdaq
- EQS Nasdaq
- Market Cap
- BOLT 16.8M
- EQS 19.0M
- IPO Year
- BOLT 2021
- EQS N/A
- Fundamental
- Price
- BOLT $5.65
- EQS $1.43
- Analyst Decision
- BOLT Buy
- EQS
- Analyst Count
- BOLT 3
- EQS 0
- Target Price
- BOLT $50.00
- EQS N/A
- AVG Volume (30 Days)
- BOLT 20.2K
- EQS 11.3K
- Earning Date
- BOLT 08-12-2025
- EQS 01-01-0001
- Dividend Yield
- BOLT N/A
- EQS N/A
- EPS Growth
- BOLT N/A
- EQS N/A
- EPS
- BOLT N/A
- EQS N/A
- Revenue
- BOLT $3,638,000.00
- EQS $1,329,000.00
- Revenue This Year
- BOLT N/A
- EQS N/A
- Revenue Next Year
- BOLT $24.14
- EQS N/A
- P/E Ratio
- BOLT N/A
- EQS N/A
- Revenue Growth
- BOLT N/A
- EQS 152.66
- 52 Week Low
- BOLT $5.20
- EQS $0.74
- 52 Week High
- BOLT $15.60
- EQS $1.52
- Technical
- Relative Strength Index (RSI)
- BOLT 47.50
- EQS 63.82
- Support Level
- BOLT $5.68
- EQS $1.35
- Resistance Level
- BOLT $6.40
- EQS $1.43
- Average True Range (ATR)
- BOLT 0.27
- EQS 0.04
- MACD
- BOLT 0.07
- EQS -0.01
- Stochastic Oscillator
- BOLT 50.00
- EQS 91.30
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.